Rosiglitazone promotes development of a novel adipocyte population from bone marrow–derived circulating progenitor cells
J. Clin. Invest. Joseph T. Crossno, et al. 116:3220 doi:10.1172/JCI28510 [Go to this article.]

Table 1
Effect of ROSI on cell-surface marker expression on PBMCs and omental and dorsal intrascapular fat stromal/vascular cells